INNV vs. TALK, PNTG, DCGO, WGS, SHCR, PIII, USPH, OABI, ZJYL, and KRRO
Should you be buying InnovAge stock or one of its competitors? The main competitors of InnovAge include Talkspace (TALK), The Pennant Group (PNTG), DocGo (DCGO), GeneDx (WGS), Sharecare (SHCR), P3 Health Partners (PIII), U.S. Physical Therapy (USPH), OmniAb (OABI), Jin Medical International (ZJYL), and Korro Bio (KRRO). These companies are all part of the "medical" sector.
InnovAge (NASDAQ:INNV) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings, community ranking and institutional ownership.
Talkspace has lower revenue, but higher earnings than InnovAge. Talkspace is trading at a lower price-to-earnings ratio than InnovAge, indicating that it is currently the more affordable of the two stocks.
12.3% of InnovAge shares are owned by institutional investors. Comparatively, 57.4% of Talkspace shares are owned by institutional investors. 0.4% of InnovAge shares are owned by insiders. Comparatively, 18.4% of Talkspace shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
InnovAge and Talkspace both received 0 outperform votes by MarketBeat users.
InnovAge has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.
In the previous week, InnovAge had 1 more articles in the media than Talkspace. MarketBeat recorded 8 mentions for InnovAge and 7 mentions for Talkspace. Talkspace's average media sentiment score of 0.31 beat InnovAge's score of 0.14 indicating that Talkspace is being referred to more favorably in the news media.
InnovAge currently has a consensus target price of $6.50, suggesting a potential upside of 66.24%. Talkspace has a consensus target price of $3.00, suggesting a potential downside of 3.85%. Given InnovAge's higher possible upside, analysts plainly believe InnovAge is more favorable than Talkspace.
InnovAge has a net margin of -4.38% compared to Talkspace's net margin of -12.78%. InnovAge's return on equity of -10.53% beat Talkspace's return on equity.
Summary
InnovAge and Talkspace tied by winning 7 of the 14 factors compared between the two stocks.
Get InnovAge News Delivered to You Automatically
Sign up to receive the latest news and ratings for INNV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INNV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
InnovAge Competitors List
Related Companies and Tools
